메뉴 건너뛰기




Volumn 16, Issue 3, 2009, Pages 93-100

Novel lipids targets in the era of metabolic syndrome: Toward a better prediction of cardiovascular risk

Author keywords

Apolipoprotein b; Cardiovascular risk; Metabolic syndrome; Non HDL cholesterol

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; ATORVASTATIN; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

EID: 70349288291     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11316980-000000000-00000     Document Type: Review
Times cited : (2)

References (65)
  • 1
    • 0035960630 scopus 로고    scopus 로고
    • Global burden of cardiovascular diseases, part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization
    • Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753
    • (2001) Circulation , vol.104 , pp. 2746-2753
    • Yusuf, S.1    Reddy, S.2    Ounpuu, S.3
  • 2
    • 3142729178 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    • National Heart Lung and Blood Institute; American College of Cardiology Foundation; American Heart Association
    • Grundy SM, Cleeman JI, Merz CN, et al., National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239
    • (2004) Circulation , vol.110 , pp. 227-239
    • Grundy, S.M.1    Cleeman, J.I.2    Merz, C.N.3
  • 3
    • 41549118416 scopus 로고    scopus 로고
    • Lipoprotein management in patients with cardiometabolic risk: Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation
    • Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008; 51: 1512-1524
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1512-1524
    • Brunzell, J.D.1    Davidson, M.2    Furberg, C.D.3
  • 4
    • 2942683422 scopus 로고    scopus 로고
    • Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyper-lipidemia in coronary artery disease risk
    • Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyper-lipidemia in coronary artery disease risk. J Clin Endocrin Metab 2004; 6: 2601-2607
    • (2004) J Clin Endocrin Metab , vol.6 , pp. 2601-2607
    • Carr, M.C.1    Brunzell, J.D.2
  • 5
    • 14944342962 scopus 로고    scopus 로고
    • Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men
    • Simon A, Chironi G, Gariepy J, et al. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis 2005; 179: 339-344
    • (2005) Atherosclerosis , vol.179 , pp. 339-344
    • Simon, A.1    Chironi, G.2    Gariepy, J.3
  • 6
    • 34250714459 scopus 로고    scopus 로고
    • Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study)
    • Frontini MG, Srinivasan SR, Xu JH, et al. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study). Am J Cardiol 2007; 100: 64-68
    • (2007) Am J Cardiol , vol.100 , pp. 64-68
    • Frontini, M.G.1    Srinivasan, S.R.2    Xu, J.H.3
  • 7
    • 57749193318 scopus 로고    scopus 로고
    • Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals
    • Orakzai SH, Nasir K, Blaha M, et al. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009; 202: 289-295
    • (2009) Atherosclerosis , vol.202 , pp. 289-295
    • Orakzai, S.H.1    Nasir, K.2    Blaha, M.3
  • 8
    • 0035865609 scopus 로고    scopus 로고
    • Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment
    • Hecht HS, Superko HR, Smith LK, et al. Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment. Am J Cardiol 2001; 87: 406-412
    • (2001) Am J Cardiol , vol.87 , pp. 406-412
    • Hecht, H.S.1    Superko, H.R.2    Smith, L.K.3
  • 9
    • 0037333159 scopus 로고    scopus 로고
    • Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
    • Sniderman AD, Furberg CD, Keech A, et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361: 777-780
    • (2003) Lancet , vol.361 , pp. 777-780
    • Sniderman, A.D.1    Furberg, C.D.2    Keech, A.3
  • 10
    • 33746218177 scopus 로고    scopus 로고
    • The apolipoprotein story
    • Sacks FM. The apolipoprotein story. Atheroscler Suppl 2006; 7: 23-27
    • (2006) Atheroscler Suppl , vol.7 , pp. 23-27
    • Sacks, F.M.1
  • 11
    • 34249654186 scopus 로고    scopus 로고
    • Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study
    • Wilson PW, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007; 167: 1068-1074
    • (2007) Arch Intern Med , vol.167 , pp. 1068-1074
    • Wilson, P.W.1    Meigs, J.B.2    Sullivan, L.3
  • 12
    • 33846422032 scopus 로고    scopus 로고
    • Obesity and diabetes in the developing world: A growing challenge
    • Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world: a growing challenge. N Engl J Med 2007; 356: 213-215
    • (2007) N Engl J Med , vol.356 , pp. 213-215
    • Hossain, P.1    Kawar, B.2    El Nahas, M.3
  • 13
    • 0037035456 scopus 로고    scopus 로고
    • Prevention Conference VI: Diabetes and cardiovascular disease executive summary - Conference proceeding for healthcare professionals from a special writing group of the American Heart Association
    • Grundy SM, Howard B, Smith Jr S, et al. Prevention Conference VI: diabetes and cardiovascular disease executive summary - conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002; 105: 2231-2239
    • (2002) Circulation , vol.105 , pp. 2231-2239
    • Grundy, S.M.1    Howard, B.2    Smith Jr. S3
  • 14
    • 0037035775 scopus 로고    scopus 로고
    • Prevention Conference VI: Diabetes and cardiovascular disease: Writing Group i - Epidemiology
    • Howard BV, Rodriguez BL, Bennett PH, et al. Prevention Conference VI: diabetes and cardiovascular disease: Writing Group I - epidemiology. Circulation 2002; 105: e132-7
    • (2002) Circulation , vol.105
    • Howard, B.V.1    Rodriguez, B.L.2    Bennett, P.H.3
  • 15
    • 0035516047 scopus 로고    scopus 로고
    • Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US
    • Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 2001; 24: 1936-1940
    • (2001) Diabetes Care , vol.24 , pp. 1936-1940
    • Boyle, J.P.1    Honeycutt, A.A.2    Narayan, K.M.3
  • 16
    • 38149005627 scopus 로고    scopus 로고
    • Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study
    • Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008; 51: 264-270
    • (2008) J Am Coll Cardiol , vol.51 , pp. 264-270
    • Levitzky, Y.S.1    Pencina, M.J.2    D'Agostino, R.B.3
  • 17
    • 0033553188 scopus 로고    scopus 로고
    • Diabetes and decline in heart disease mortality in US adults
    • GuK, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999; 281: 1291-1297
    • (1999) JAMA , vol.281 , pp. 1291-1297
    • Guk Cowie, C.C.1    Harris, M.I.2
  • 18
    • 0037965978 scopus 로고    scopus 로고
    • Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction
    • Norhammar A, Malmberg K, Rydé n L, et al., Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838-844
    • (2003) Eur Heart J , vol.24 , pp. 838-844
    • Norhammar, A.1    Malmberg, K.2    Ryden, L.3
  • 19
    • 3142738757 scopus 로고    scopus 로고
    • GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. the global registry of acute coronary events
    • Franklin K, Goldberg RJ, Spencer F, et al., GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004; 164: 1457-1463
    • (2004) Arch Intern Med , vol.164 , pp. 1457-1463
    • Franklin, K.1    Goldberg, R.J.2    Spencer, F.3
  • 20
    • 0036701017 scopus 로고    scopus 로고
    • A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey SCA)
    • Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey SCA). Eur Heart J 2002; 23: 1190-1201
    • (2002) Eur Heart J , vol.23 , pp. 1190-1201
    • Hasdai, D.1    Behar, S.2    Wallentin, L.3
  • 21
    • 0034730110 scopus 로고    scopus 로고
    • Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry
    • Malmberg K, Yusuf S, Gerstein Hc, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000; 102: 1014-1019
    • (2000) Circulation , vol.102 , pp. 1014-1019
    • Malmberg, K.1    Yusuf, S.2    Hc, G.3
  • 22
    • 27444443876 scopus 로고    scopus 로고
    • Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart Lung and Blood Institute Scientific Statement
    • American Heart Association; National Heart Lung and Blood Institute
    • Grundy SM, Cleeman JI, Daniels SR, et al., American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
    • (2005) Circulation , vol.112 , pp. 2735-2752
    • Grundy, S.M.1    Cleeman, J.I.2    Daniels, S.R.3
  • 23
    • 0037116641 scopus 로고    scopus 로고
    • Prevalence of the MetS among US adults: Findings from the third National Health and Nutrition Examination Survey
    • Ford ES, Giles WH, Dietz WH. Prevalence of the MetS among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
    • (2002) JAMA , vol.287 , pp. 356-359
    • Ford, E.S.1    Giles, W.H.2    Dietz, W.H.3
  • 24
    • 33846970555 scopus 로고    scopus 로고
    • Metabolic syndrome: A multiplex cardiovascular risk factor
    • Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 399-404
    • Grundy, S.M.1
  • 25
    • 0037463608 scopus 로고    scopus 로고
    • The MetS: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
    • Park YW, Zhu S, Palaniappan L, et al. The MetS: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436
    • (2003) Arch Intern Med , vol.163 , pp. 427-436
    • Park, Y.W.1    Zhu, S.2    Palaniappan, L.3
  • 26
    • 0036558732 scopus 로고    scopus 로고
    • Abdominal obesity is associated with increased risk of acute coronary events in men
    • Lakka HM, Lakka TA, Tuomilehto J, et al. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002; 23: 706-713
    • (2002) Eur Heart J , vol.23 , pp. 706-713
    • Lakka, H.M.1    Lakka, T.A.2    Tuomilehto, J.3
  • 27
    • 34249650811 scopus 로고    scopus 로고
    • Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes
    • Ingelsson E, Sullivan LM, Murabito JM, et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007; 56: 1718-1726
    • (2007) Diabetes , vol.56 , pp. 1718-1726
    • Ingelsson, E.1    Sullivan, L.M.2    Murabito, J.M.3
  • 28
    • 33846365989 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies
    • Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414
    • (2007) J Am Coll Cardiol , vol.49 , pp. 403-414
    • Gami, A.S.1    Witt, B.J.2    Howard, D.E.3
  • 29
    • 34447309619 scopus 로고    scopus 로고
    • Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
    • Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116: 151-157
    • (2007) Circulation , vol.116 , pp. 151-157
    • Barr, E.L.1    Zimmet, P.Z.2    Welborn, T.A.3
  • 30
    • 33845881411 scopus 로고    scopus 로고
    • Mechanisms linking obesity to insulin resistance and type 2 diabetes
    • Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846
    • (2006) Nature , vol.444 , pp. 840-846
    • Kahn, S.E.1    Hull, R.L.2    Utzschneider, K.M.3
  • 31
    • 0348162332 scopus 로고    scopus 로고
    • Insulin resistance: From benign to type 2 diabetes mellitus
    • Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med 2003; 4 Suppl. 6: S3-10
    • (2003) Rev Cardiovasc Med , vol.4 , Issue.SUPPL. 6
    • Goldstein, B.J.1
  • 32
    • 64749100502 scopus 로고    scopus 로고
    • Patterns of abdominal fat distribution: The Framingham Heart Study
    • Pou KM, Massaro JM, Hoffmann U, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32 (3): 481-485
    • (2009) Diabetes Care , vol.32 , Issue.3 , pp. 481-485
    • Pou, K.M.1    Massaro, J.M.2    Hoffmann, U.3
  • 33
    • 34347351228 scopus 로고    scopus 로고
    • Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study
    • Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48
    • (2007) Circulation , vol.116 , pp. 39-48
    • Fox, C.S.1    Massaro, J.M.2    Hoffmann, U.3
  • 34
    • 0023807047 scopus 로고
    • Low-density lipoprotein subclass patterns and risk of myocardial infarction
    • Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-1921
    • (1988) JAMA , vol.260 , pp. 1917-1921
    • Austin, M.A.1    Breslow, J.L.2    Hennekens, C.H.3
  • 35
    • 17144380822 scopus 로고    scopus 로고
    • The metabolic syndrome
    • RB, et al. Impact of impaired fasting
    • Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; RB, et al. Impact of impaired fasting 365: 1415-1428
    • (2005) Lancet , vol.365 , pp. 1415-1428
    • Eckel, R.H.1    Grundy, S.M.2    Zimmet, P.Z.3
  • 36
    • 9444285816 scopus 로고    scopus 로고
    • Dyslipidemia and the metabolic syndrome
    • Bloomgarden ZT. Dyslipidemia and the metabolic syndrome. Diabetes Care 2004; 27: 3009-3016
    • (2004) Diabetes Care , vol.27 , pp. 3009-3016
    • Bloomgarden, Z.T.1
  • 37
    • 84910110212 scopus 로고    scopus 로고
    • The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
    • Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000; 7: 325-331
    • (2000) J Cardiovasc Risk , vol.7 , pp. 325-331
    • Ginsberg, H.N.1    Huang, L.S.2
  • 38
    • 31744450497 scopus 로고    scopus 로고
    • Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia
    • Kolovou GD, Anagnostopoulou K, Pilatis ND, et al. Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia. Vasc Health Risk Manag 2005; 1: 155-161
    • (2005) Vasc Health Risk Manag , vol.1 , pp. 155-161
    • Kolovou, G.D.1    Anagnostopoulou, K.2    Pilatis, N.D.3
  • 39
    • 0027502421 scopus 로고
    • Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
    • Chait A, Brazg RL, Tribble DL, et al. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993; 94: 350-356
    • (1993) Am J Med , vol.94 , pp. 350-356
    • Chait, A.1    Brazg, R.L.2    Tribble, D.L.3
  • 40
    • 0031890581 scopus 로고    scopus 로고
    • Atherogenic, dense low-density lipoproteins: Pathophysiology and new therapeutic approaches
    • Chapman MJ, Gué rin M, Bruckert E. Atherogenic, dense low-density lipoproteins: pathophysiology and new therapeutic approaches. Eur Heart J 1998; 19 Suppl. A: A24-30
    • (1998) Eur Heart J , vol.19 , Issue.SUPPL. A
    • Chapman, M.J.1    Guerin, M.2    Bruckert, E.3
  • 41
    • 0026682450 scopus 로고
    • Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size
    • Tribble DL, Holl LG, Wood PD, et al. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992; 93: 189-199
    • (1992) Atherosclerosis , vol.93 , pp. 189-199
    • Tribble, D.L.1    Holl, L.G.2    Wood, P.D.3
  • 42
    • 0025977492 scopus 로고
    • Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
    • De Graaf J, Hak-Lemmers HL, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298-306
    • (1991) Arterioscler Thromb , vol.11 , pp. 298-306
    • De Graaf, J.1    Hak-Lemmers, H.L.2    Hectors, M.P.3
  • 43
    • 0242300697 scopus 로고    scopus 로고
    • The coming of age of the metabolic syndrome
    • Alexander CM. The coming of age of the metabolic syndrome. Diabetes Care 2003; 26: 3180-3181
    • (2003) Diabetes Care , vol.26 , pp. 3180-3181
    • Alexander, C.M.1
  • 44
    • 33645089715 scopus 로고    scopus 로고
    • Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men
    • St-Pierre AC, Cantin B, Dagenais GR, et al. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. Am J Cardiol 2006; 97: 997-1001
    • (2006) Am J Cardiol , vol.97 , pp. 997-1001
    • St-Pierre, A.C.1    Cantin, B.2    Dagenais, G.R.3
  • 45
    • 33644876621 scopus 로고    scopus 로고
    • Apolipoprotein B versus non-high-density lipoprotein cholesterol: And the winner is
    • Sniderman AD. Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is... Circulation 2005; 112: 3366-3367
    • (2005) Circulation , vol.112 , pp. 3366-3367
    • Sniderman, A.D.1
  • 46
    • 33644874294 scopus 로고    scopus 로고
    • Weighing in before the fight: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy
    • Denke MA. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Circulation 2005; 112: 3368-3370
    • (2005) Circulation , vol.112 , pp. 3368-3370
    • Denke, M.A.1
  • 47
    • 2142771357 scopus 로고    scopus 로고
    • Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: Alternatives and surrogates versus the real thing
    • Sniderman AD. Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: alternatives and surrogates versus the real thing. Diabetes Care 2003; 26: 2207-2208
    • (2003) Diabetes Care , vol.26 , pp. 2207-2208
    • Sniderman, A.D.1
  • 48
    • 0037069434 scopus 로고    scopus 로고
    • Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Re-vascularization Investigation (BARI).; Bypass Angioplasty Revasculari-zation Investigation
    • Nov 12
    • Bittner V, Hardison R, Kelsey SF, et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Re-vascularization Investigation (BARI).; Bypass Angioplasty Revasculari-zation Investigation. Circulation 2002 Nov 12; 106 (20): 2537-2542
    • (2002) Circulation , vol.106 , Issue.20 , pp. 2537-2542
    • Bittner, V.1    Hardison, R.2    Kelsey, S.F.3
  • 49
    • 3342958811 scopus 로고    scopus 로고
    • Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes
    • Jiang R, Schulze MB, Li T, et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004; 27: 1991-1997
    • (2004) Diabetes Care , vol.27 , pp. 1991-1997
    • Jiang, R.1    Schulze, M.B.2    Li, T.3
  • 50
    • 23044485065 scopus 로고    scopus 로고
    • Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
    • Liu J, Sempos C, Donahue RP, et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005; 28: 1916-1921
    • (2005) Diabetes Care , vol.28 , pp. 1916-1921
    • Liu, J.1    Sempos, C.2    Donahue, R.P.3
  • 51
    • 22244446183 scopus 로고    scopus 로고
    • Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
    • Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-333
    • (2005) JAMA , vol.294 , pp. 326-333
    • Ridker, P.M.1    Rifai, N.2    Cook, N.R.3
  • 52
    • 33750527116 scopus 로고    scopus 로고
    • Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease
    • Liu J, Sempos CT, Donahue RP, et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006; 98: 1363-1368
    • (2006) Am J Cardiol , vol.98 , pp. 1363-1368
    • Liu, J.1    Sempos, C.T.2    Donahue, R.P.3
  • 53
    • 0034912018 scopus 로고    scopus 로고
    • Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
    • Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161: 1413-1419
    • (2001) Arch Intern Med , vol.161 , pp. 1413-1419
    • Cui, Y.1    Blumenthal, R.S.2    Flaws, J.A.3
  • 54
    • 35848958806 scopus 로고    scopus 로고
    • Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
    • Chien KL, Hsu HC, Su TC, et al. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 2007; 48: 2499-2505
    • (2007) J Lipid Res , vol.48 , pp. 2499-2505
    • Chien, K.L.1    Hsu, H.C.2    Su, T.C.3
  • 55
    • 0037479469 scopus 로고    scopus 로고
    • Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The strong heart study
    • Lu W, Resnick HE, Jablonski KA, et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003; 26: 16-23
    • (2003) Diabetes Care , vol.26 , pp. 16-23
    • Lu, W.1    Resnick, H.E.2    Jablonski, K.A.3
  • 56
    • 33644873843 scopus 로고    scopus 로고
    • Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
    • Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005; 112: 3375-3383
    • (2005) Circulation , vol.112 , pp. 3375-3383
    • Pischon, T.1    Girman, C.J.2    Sacks, F.M.3
  • 57
    • 34547876797 scopus 로고    scopus 로고
    • Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
    • Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007; 298: 776-785
    • (2007) JAMA , vol.298 , pp. 776-785
    • Ingelsson, E.1    Schaefer, E.J.2    Contois, J.H.3
  • 58
    • 58249086417 scopus 로고    scopus 로고
    • Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk
    • Robinson JG, Wang S, Smith BJ, et al. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol 2009; 53: 316-322
    • (2009) J Am Coll Cardiol , vol.53 , pp. 316-322
    • Robinson, J.G.1    Wang, S.2    Smith, B.J.3
  • 59
    • 23744501476 scopus 로고    scopus 로고
    • Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
    • Shepherd J. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes? Atheroscler Suppl 2005; 6: 15-19
    • (2005) Atheroscler Suppl , vol.6 , pp. 15-19
    • Shepherd, J.1
  • 60
    • 34548433987 scopus 로고    scopus 로고
    • Clinical practice: Hypertriglyceridemia
    • Sep 6
    • Brunzell JD. Clinical practice: hypertriglyceridemia. N Engl J Med 2007 Sep 6; 357 (10): 1009-1017
    • (2007) N Engl J Med , vol.357 , Issue.10 , pp. 1009-1017
    • Brunzell, J.D.1
  • 61
    • 0037069339 scopus 로고    scopus 로고
    • Low-density lipoprotein, non-high-density lipoprotein, and apolipo-protein B as targets of lipid-lowering therapy
    • Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipo-protein B as targets of lipid-lowering therapy. Circulation 2002; 106: 2526-2529
    • (2002) Circulation , vol.106 , pp. 2526-2529
    • Grundy, S.M.1
  • 62
    • 48849112223 scopus 로고    scopus 로고
    • Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: The MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial
    • Ballantyne CM, Raichlen JS, Cain VA. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. J Am Coll Cardiol 2008; 52: 626-632
    • (2008) J Am Coll Cardiol , vol.52 , pp. 626-632
    • Ballantyne, C.M.1    Raichlen, J.S.2    Cain, V.A.3
  • 63
    • 0032554686 scopus 로고    scopus 로고
    • Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
    • Pedersen TR, Olsson AG, Faergeman O, et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 1998; 97: 1453-1460
    • (1998) Circulation , vol.97 , pp. 1453-1460
    • Pedersen, T.R.1    Olsson, A.G.2    Faergeman, O.3
  • 64
    • 0037834856 scopus 로고    scopus 로고
    • Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment
    • Athyros VG, Papageorgiou AA, Symeonidis AN, et al. Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment. Atherosclerosis 2003; 168: 397-398
    • (2003) Atherosclerosis , vol.168 , pp. 397-398
    • Athyros, V.G.1    Papageorgiou, A.A.2    Symeonidis, A.N.3
  • 65
    • 50649115698 scopus 로고    scopus 로고
    • Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. insights from the incremental decrease in end-points through aggressive lipid-lowering trial (IDEAL)
    • Lipid-Lowering Study Group
    • Holme I, Cater NB, Faergeman O, et al. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. insights from the incremental decrease in end-points through aggressive lipid-lowering trial (IDEAL). Lipid-Lowering Study Group. Ann Med 2008; 40: 456-464
    • (2008) Ann Med , vol.40 , pp. 456-464
    • Holme, I.1    Cater, N.B.2    Faergeman, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.